Royalties in Tech Transfer Alliances
In Vivo reviews recent royalty rates in tech transfer-to-biotech licensing deals.
You may also be interested in...
How do the financial terms of deals signed with university tech transfer offices differ when the licensor is a biotech, compared to a Big Pharma? We broke out university deals signed by these kinds of licensors to find out.
American Injectables plans to build up its US-based manufacturing after securing a commitment for $10m of ‘Series A’ financing from New Rhein Healthcare Investors, which it will use to scale up production and launch several generic parenteral products.
A draft EU guideline explains how disease registries can be used to supplement evidence in the pre-authorization phase and provide infrastructure for post-authorization evidence generation.